Cartesian Therapeutics (RNAC) Insider Trading & Ownership $17.02 -0.10 (-0.58%) (As of 11/14/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Cartesian Therapeutics (NASDAQ:RNAC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage57.90%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$2.38 MNumber OfInsiders Selling(Last 12 Months)0 Get RNAC Insider Trade Alerts Want to know when executives and insiders are buying or selling Cartesian Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RNAC Insider Buying and Selling by Quarter Ad Crypto 101 MediaMusk Says ‘Dollar Will Be Worth Nothing…’Cash In On the Pro-Crypto America 27 experts reveal their top picks for 2025 Click here to reserve your seat at the Crypto Community Summit. Cartesian Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/4/2024Timothy A SpringerDirectorBuy80,301$22.58$1,813,196.58 10/2/2024Timothy A SpringerDirectorBuy5,514$17.38$95,833.32 8/12/2024Timothy A SpringerDirectorBuy8,016$12.72$101,963.52 3/18/2024Timothy A SpringerDirectorBuy634$18.00$11,412.00 3/14/2024Timothy A SpringerDirectorBuy21,612$16.20$350,114.40 3/11/2024Timothy A SpringerDirectorBuy40$19.50$780.00 3/8/2024Timothy A SpringerDirectorBuy160$19.80$3,168.00 2/6/2024Timothy A SpringerDirectorBuy26$19.50$507.00 1/17/2024Timothy A SpringerDirectorBuy26$20.70$538.20 (Data available from 1/1/2013 forward) RNAC Insider Trading Activity - Frequently Asked Questions Who is on Cartesian Therapeutics's Insider Roster? The list of insiders at Cartesian Therapeutics includes Timothy A Springer. Learn more on insiders at RNAC. What percentage of Cartesian Therapeutics stock is owned by insiders? 57.90% of Cartesian Therapeutics stock is owned by insiders. Learn more on RNAC's insider holdings. Which Cartesian Therapeutics insiders have been buying company stock? The following insider purchased RNAC shares in the last 24 months: Timothy A Springer ($2,377,513.02). How much insider buying is happening at Cartesian Therapeutics? Insiders have purchased a total of 116,329 RNAC shares in the last 24 months for a total of $2,377,513.02 bought. Cartesian Therapeutics Key ExecutivesDr. Carsten Brunn Ph.D. (Age 53)President, CEO & Director Compensation: $4.67MMr. Blaine T. Davis (Age 50)Chief Financial Officer Compensation: $2.49MDr. Metin Kurtoglu M.D. (Age 45)Ph.D., Chief Technology Officer Compensation: $398.28kDr. Chris Jewell Ph.D. (Age 42)Chief Scientific Officer Compensation: $296.85kMr. Matthew Bartholomae J.D.General Counsel & SecretaryDr. Milos Miljkovic M.D. (Age 40)Ph.D., Chief Medical Officer Dr. Emily English Ph.D. (Age 44)SVP & Head of Manufacturing Mr. Yi Zhang Ph.D.Senior Director of Technology More Insider Trading Tools from MarketBeat Related Companies IMCR Insider Buying OCUL Insider Buying KNSA Insider Buying DAWN Insider Buying SPRY Insider Buying XNCR Insider Buying RCUS Insider Buying NTLA Insider Buying RCKT Insider Buying TVTX Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NASDAQ:RNAC) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredElon Musk has put himself in their crosshairsToday, I have another controversial prediction. One which I will take no pleasure in seeing come true. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cartesian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cartesian Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
